Related Experiment Videos
FloSeal: a new hemostyptic agent in peripheral vascular surgery
O Reuthebuch1, M L Lachat, P Vogt
1Clinic for Cardiovascular Surgery, University Hospital Zürich, Switzerland. oliver.reuthebuch@chi.usz.ch
VASA. Zeitschrift Fur Gefasskrankheiten
|October 19, 2000
Summary
FloSeal effectively controlled bleeding in most vascular surgery patients. This new sealant offers an advantageous hemostatic option, proving safe and efficient for achieving a dry surgical field.
Area of Science:
- Vascular Surgery
- Surgical Hemostasis
Background:
- Bleeding is a significant complication in vascular surgery.
- Current sealants are less effective on bloody surfaces.
- A new sealant, FloSeal, was evaluated for its efficacy.
Purpose of the Study:
- To assess the effectiveness of FloSeal in controlling bleeding during vascular surgery.
- To determine if FloSeal can achieve a dry surgical field.
Main Methods:
- 17 patients undergoing peripheral vascular interventions were studied.
- Effectiveness was measured by bleeding severity, time to hemostasis, and need for additional measures.
- FloSeal was applied to achieve hemostasis.
Main Results:
- FloSeal successfully controlled bleeding in 15 out of 17 patients.
- Two patients required additional hemostatic treatment.
- No local or systemic complications were observed.
Conclusions:
- FloSeal is an effective hemostatic tool for vascular surgery.
- It offers an advantageous option for managing surgical bleeding.
- The sealant demonstrated a favorable safety profile.